Donate

Canberra In-Person Patient Education Day

We are excited to invite you to our upcoming In-Person Patient Education Day in Canberra this July.

This education day will include the following topics:

  • Discussing the changing landscape of treating lymphoma and CLL
  • Supportive care after Lymphoma Treatment: Practical strategies for recovery and wellbeing.

Guest Speakers

Dr Pietro Di Ciaccio, Staff Haematologist, The Canberra Hospital

Dr Pietro Di Ciaccio is a specialist haematologist, with fellowships from both the Royal Australasian College of Physicians and Royal College of Pathologists Australasia. He specialises in all varieties of malignant, non-malignant and obstetric haematology, with particular interest in lymphoma.

Dr Di Ciaccio cares for patients at The Canberra Hospital in the Australian Capital Territory. He also has a monthly clinic in Goulburn in the southern highlands of regional New South Wales.

In addition to clinical haematology, Dr Di Ciaccio also works as a haematopathologist at Capital Pathology (Sonic Healthcare), and is a lecturer at the Australian National University. He is the current Chair of the Australasian Lymphoma Alliance (ALA).​

Dr Di Ciaccio has expertise in health medicine and is a Fellow of the Australasian College of Legal Medicine. He speaks Italian, and prior to a career in medicine completed degrees in Arts and Law. 

Nicole Weekes, Lymphoma Care Nurse, Lymphoma Australia

Nicole Weekes is a Lead Lymphoma Care Nurse working across Lymphoma Australia and South Western Sydney Local Health District. She has over 15 years of haematology nursing experience and holds a Master’s degree in Cancer and Haematology Nursing.

Nicole is recognised for delivering advanced, patient‑centred care across the full haematology continuum, from diagnosis through to survivorship. She coordinates complex treatments and supports patients to achieve their best possible outcomes.

Known for her compassionate approach, Nicole offers kind, consistent emotional support to patients and their families during what is often a highly challenging time, ensuring they feel informed, supported, and empowered throughout their journey.

Agenda

Arrival 10am Registrations
Presentation 1 10:15am – 11:00am The changing landscape of treating Lymphoma and CLL – Dr Pietro Di Ciaccio
Presentation 2 11:15am – 12:00pm Supportive care after Lymphoma treatment: Practical strategies for recovery and wellbeing – Nicole Weekes
Lunch 12:00pm – 1:00pm Complimentary lunch, providing time for attendees to meet and connect with fellow patients.
Close 1:00pm Wrap Up and Close

There is limited availability for this event, so secure your spot quickly.
This event has already taken place.
Details
Date: Wednesday 29th of July 2026
Time: 10:00am AEST - 12:30pm AEST
Location: John James Village Recreation Room
2 Rusden St, Garran ACT 2605
Register to attend
Download Flyer

Support and information

Support Groups & Social Media

Find Out More

Factsheets & Booklets

Find Out More

Fundraise for us

Get started

Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.